HPV VACCINATION - PROPHYLACTIC CONDUCT
Following the screening made as part of the research, during April 2010–2011, and as immediate result of realizing the seriousness of the disease and the long term consequences caused by cervical neoplasia, 1143 women accepted vaccination, which means 6.8% of the patients who came for a consult at t...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Alexandru Ioan Cuza" University of Iași
2012-06-01
|
Series: | Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara |
Online Access: | http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/965 |
id |
doaj-bba0b05033b94f909bf33dddf5a08661 |
---|---|
record_format |
Article |
spelling |
doaj-bba0b05033b94f909bf33dddf5a086612020-11-24T23:05:08Zeng"Alexandru Ioan Cuza" University of IașiAnalele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara 1582-35712248-32762012-06-011322731959HPV VACCINATION - PROPHYLACTIC CONDUCTEduard CrauciucDorin NeacsuOvidiu TomaDragos CrauciucFollowing the screening made as part of the research, during April 2010–2011, and as immediate result of realizing the seriousness of the disease and the long term consequences caused by cervical neoplasia, 1143 women accepted vaccination, which means 6.8% of the patients who came for a consult at the surgeries in Iaúi and Buzău. After analyzing the epidemiologic characteristics we can draw the conclusion that women aged between 20-29 years old, coming from the cities and having a high education were the most frequent ones to accept vaccination. The most frequently used vaccine was Silgard (60.9%).http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/965 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eduard Crauciuc Dorin Neacsu Ovidiu Toma Dragos Crauciuc |
spellingShingle |
Eduard Crauciuc Dorin Neacsu Ovidiu Toma Dragos Crauciuc HPV VACCINATION - PROPHYLACTIC CONDUCT Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara |
author_facet |
Eduard Crauciuc Dorin Neacsu Ovidiu Toma Dragos Crauciuc |
author_sort |
Eduard Crauciuc |
title |
HPV VACCINATION - PROPHYLACTIC CONDUCT |
title_short |
HPV VACCINATION - PROPHYLACTIC CONDUCT |
title_full |
HPV VACCINATION - PROPHYLACTIC CONDUCT |
title_fullStr |
HPV VACCINATION - PROPHYLACTIC CONDUCT |
title_full_unstemmed |
HPV VACCINATION - PROPHYLACTIC CONDUCT |
title_sort |
hpv vaccination - prophylactic conduct |
publisher |
"Alexandru Ioan Cuza" University of Iași |
series |
Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara |
issn |
1582-3571 2248-3276 |
publishDate |
2012-06-01 |
description |
Following the screening made as part of the research, during April 2010–2011, and as immediate result of realizing the seriousness of the disease and the long term consequences caused by cervical neoplasia, 1143 women accepted vaccination, which means 6.8% of the patients who came for a consult at the surgeries in Iaúi and Buzău. After analyzing the epidemiologic characteristics we can draw the conclusion that women aged between 20-29 years old, coming from the cities and having a high education were the most frequent ones to accept vaccination. The most frequently used vaccine was Silgard (60.9%). |
url |
http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/965 |
work_keys_str_mv |
AT eduardcrauciuc hpvvaccinationprophylacticconduct AT dorinneacsu hpvvaccinationprophylacticconduct AT ovidiutoma hpvvaccinationprophylacticconduct AT dragoscrauciuc hpvvaccinationprophylacticconduct |
_version_ |
1725627308479348736 |